tripleG

‘Triple-G’ weight loss drug update: Even on the lowest dose, trial patients lost 12.7% of their weight

by
‘Triple-G’ weight loss drug update: Even on the lowest dose, trial patients lost 12.7% of their weight

We’re learning more about the super-effective “triple-G” weight loss drug retatrutide. The drug, the first of its kind to target three metabolic receptors (GLP-1, GIP, and glucagon), is nearing the end of clinical trials and is expected to be submitted to the FDA for approval early next year. People are already clamoring to get their … Read more

What to know about new ‘triple-G’ drug that’s helped patients lose a quarter of their body weight

by
What to know about new ‘triple-G’ drug that’s helped patients lose a quarter of their body weight

G whiz! The latest experimental GLP-1 from Eli Lilly isn’t just a diabetes drug — it also facilitates weight loss. Known as “triple-G,” injectable retatrutide levies a triple whammy on the GLP-1, GIP and glucagon hormones, whereas most other drugs on the market only mimic one or two of those hormones. Eli Lilly’s new retatrutide drug … Read more